Division of Parasitology, CSIR-Central Drug Research Institute, Lucknow; Academy of Scientific & Innovative Research, New Delhi, India.
ICMR-National Institute of Malaria Research, New Delhi, India.
Indian J Med Res. 2017 Nov;146(5):622-628. doi: 10.4103/ijmr.IJMR_1688_15.
BACKGROUND & OBJECTIVES: : The in vitro assays for susceptibility of Plasmodium falciparum to antimalarial drugs are important tools for monitoring drug resistance. During the present study, efforts were made to establish long-term continuous in vitro culture of Indian field isolates of P. falciparum and to determine their sensitivity to standard antimalarial drugs and antibiotics.
Four (MZR-I, -II, -III and -IV) P. falciparum isolates were obtained from four patients who showed artemisinin-based combination therapy (ACT) from Mizoram, a north-eastern State of India, and characterized for their in vitro susceptibility to chloroquine diphosphate (CQ), quinine hydrochloride dehydrate, mefloquine, piperaquine, artemether, arteether, dihydro-artemisinin (DHA), lumefantrine and atovaquone and antibiotics, azithromycin and doxycycline. These patients showed ACT treatment failure. Two-fold serial dilutions of each drug were tested and the effect was evaluated using the malaria SYBR Green I fluorescence assay. K1 (chloroquine-resistant) and 3D7 (chloroquine-sensitive) reference strains were used as controls.
Growth profile of all field isolates was identical to that of reference parasites. The IC50 values of all the drugs were also similar against field isolates and reference parasite strains, except K1, exhibited high IC50 value (275±12.5 nM) of CQ for which it was resistant. All field isolates exhibited higher IC50 values of CQ, quinine hydrochloride dihydrate and DHA compared to reference strains. The resistance index of field isolates with respect to 3D7 ranged between 260.55 and 403.78 to CQ, 39.83 and 46.42 to quinine, and 2.98 and 4.16 to DHA, and with respect to K1 strain ranged between 6.51 and 10.08, 39.26 and 45.75, and 2.65 and 3.71. MZR-I isolate exhibited highest resistance index.
INTERPRETATION & CONCLUSIONS: As the increase in IC50 and IC90 values of DHA against field isolates of P. falciparum was not significant, the tolerance to DHA-piperaquine (PPQ) combination might be because of PPQ only. Further study is required on more number of such isolates to generate data for a meaningful conclusion.
体外抗疟药物敏感性试验是监测药物耐药性的重要工具。本研究旨在建立印度野外分离株恶性疟原虫的长期连续体外培养,并确定其对标准抗疟药物和抗生素的敏感性。
从印度东北部米佐拉姆邦的 4 例出现青蒿素为基础的联合治疗(ACT)失败的患者中获得 4 株(MZR-I、-II、-III 和 -IV)恶性疟原虫分离株,并对其氯磷酸二喹啉(CQ)、盐酸奎宁、甲氟喹、哌喹、青蒿琥酯、青蒿琥酯、双氢青蒿素(DHA)、咯萘啶和阿托伐醌的体外敏感性以及抗生素阿奇霉素和强力霉素进行了特征描述。用疟原虫 SYBR Green I 荧光法检测每种药物的两倍系列稀释液的效果,并用 K1(抗氯喹)和 3D7(氯喹敏感)参考株作为对照。
所有野外分离株的生长曲线与参考寄生虫相同。除 K1 对 CQ 表现出高 IC50 值(275±12.5 nM)耐药外,所有药物对野外分离株和参考株的 IC50 值也相似。所有野外分离株对 CQ、盐酸奎宁二水合物和 DHA 的 IC50 值均高于参考株。与 3D7 相比,野外分离株对 CQ 的耐药指数在 260.55 至 403.78 之间,对奎宁的耐药指数在 39.83 至 46.42 之间,对 DHA 的耐药指数在 2.98 至 4.16 之间,与 K1 株相比,耐药指数在 6.51 至 10.08 之间,对奎宁的耐药指数在 39.26 至 45.75 之间,对 DHA 的耐药指数在 2.65 至 3.71 之间。MZR-I 分离株表现出最高的耐药指数。
由于 DHA 对恶性疟原虫野外分离株的 IC50 和 IC90 值增加不显著,因此对 DHA-哌喹(PPQ)联合用药的耐受性可能仅因为 PPQ。需要对更多此类分离株进行进一步研究,以生成有意义结论的数据。